Free Trial

Cardinal Health, Inc. $CAH Shares Sold by Curi RMB Capital LLC

Cardinal Health logo with Medical background

Key Points

  • Curi RMB Capital LLC reduced its stake in Cardinal Health, Inc. by 5.5%, holding $4.27 million worth of the stock at the end of the first quarter.
  • The company reported $60.16 billion in revenue for the quarter, which was below analyst estimates of $60.91 billion.
  • Cardinal Health announced a quarterly dividend of $0.5107 per share, with a dividend yield of 1.4%, to be paid on October 15th.
  • Five stocks to consider instead of Cardinal Health.

Curi RMB Capital LLC lessened its stake in shares of Cardinal Health, Inc. (NYSE:CAH - Free Report) by 5.5% in the first quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 31,004 shares of the company's stock after selling 1,800 shares during the quarter. Curi RMB Capital LLC's holdings in Cardinal Health were worth $4,271,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds also recently added to or reduced their stakes in the business. Greykasell Wealth Strategies Inc. bought a new position in Cardinal Health in the first quarter worth $26,000. Tompkins Financial Corp increased its holdings in Cardinal Health by 106.7% in the 1st quarter. Tompkins Financial Corp now owns 248 shares of the company's stock worth $34,000 after buying an additional 128 shares in the last quarter. GW&K Investment Management LLC increased its holdings in Cardinal Health by 113.4% in the 1st quarter. GW&K Investment Management LLC now owns 271 shares of the company's stock worth $37,000 after buying an additional 144 shares in the last quarter. Measured Risk Portfolios Inc. purchased a new position in Cardinal Health in the fourth quarter worth about $47,000. Finally, NBC Securities Inc. purchased a new position in Cardinal Health in the first quarter worth about $48,000. Hedge funds and other institutional investors own 87.17% of the company's stock.

Insider Activity at Cardinal Health

In other Cardinal Health news, insider Jessica L. Mayer sold 38,078 shares of the firm's stock in a transaction that occurred on Tuesday, August 19th. The stock was sold at an average price of $148.82, for a total value of $5,666,767.96. Following the sale, the insider directly owned 48,457 shares of the company's stock, valued at approximately $7,211,370.74. This trade represents a 44.00% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, CEO Jason M. Hollar sold 35,901 shares of the business's stock in a transaction on Wednesday, August 20th. The stock was sold at an average price of $150.04, for a total value of $5,386,586.04. Following the transaction, the chief executive officer directly owned 200,000 shares in the company, valued at $30,008,000. This trade represents a 15.22% decrease in their position. The disclosure for this sale can be found here. Insiders have sold 271,676 shares of company stock valued at $40,489,525 over the last 90 days. Company insiders own 0.09% of the company's stock.

Analysts Set New Price Targets

Several brokerages have issued reports on CAH. Citigroup reissued a "neutral" rating and issued a $170.00 target price (up from $157.00) on shares of Cardinal Health in a research report on Friday, June 13th. UBS Group reissued a "buy" rating on shares of Cardinal Health in a research report on Tuesday, August 12th. Argus set a $189.00 target price on Cardinal Health in a research report on Friday, August 22nd. Bank of America raised their target price on Cardinal Health from $165.00 to $170.00 and gave the stock a "buy" rating in a research report on Tuesday, June 10th. Finally, Jefferies Financial Group set a $150.00 price objective on Cardinal Health in a research report on Tuesday, August 12th. Twelve investment analysts have rated the stock with a Buy rating and three have issued a Hold rating to the company. According to MarketBeat.com, Cardinal Health presently has an average rating of "Moderate Buy" and an average target price of $165.93.

Read Our Latest Analysis on Cardinal Health

Cardinal Health Stock Performance

NYSE:CAH traded down $1.06 during trading hours on Wednesday, reaching $149.88. The stock had a trading volume of 473,463 shares, compared to its average volume of 2,401,052. Cardinal Health, Inc. has a 52 week low of $106.54 and a 52 week high of $168.44. The company has a 50 day moving average price of $155.25 and a two-hundred day moving average price of $147.29. The stock has a market capitalization of $35.79 billion, a PE ratio of 23.22, a PEG ratio of 1.27 and a beta of 0.73.

Cardinal Health (NYSE:CAH - Get Free Report) last released its earnings results on Tuesday, August 12th. The company reported $2.08 earnings per share for the quarter, beating the consensus estimate of $2.03 by $0.05. The firm had revenue of $60.16 billion for the quarter, compared to the consensus estimate of $60.91 billion. Cardinal Health had a negative return on equity of 74.45% and a net margin of 0.70%.The company's revenue for the quarter was up .5% compared to the same quarter last year. During the same quarter in the previous year, the company posted $1.84 EPS. Cardinal Health has set its FY 2026 guidance at 9.300-9.500 EPS. Equities research analysts predict that Cardinal Health, Inc. will post 7.95 EPS for the current year.

Cardinal Health Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Wednesday, October 15th. Investors of record on Wednesday, October 1st will be given a dividend of $0.5107 per share. The ex-dividend date of this dividend is Wednesday, October 1st. This represents a $2.04 dividend on an annualized basis and a yield of 1.4%. Cardinal Health's dividend payout ratio (DPR) is presently 31.63%.

Cardinal Health Company Profile

(Free Report)

Cardinal Health, Inc operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home.

Featured Articles

Institutional Ownership by Quarter for Cardinal Health (NYSE:CAH)

Should You Invest $1,000 in Cardinal Health Right Now?

Before you consider Cardinal Health, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Cardinal Health wasn't on the list.

While Cardinal Health currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

 The Best Nuclear Energy Stocks to Buy Cover

Nuclear energy stocks are roaring. It's the hottest energy sector of the year. Cameco Corp, Paladin Energy, and BWX Technologies were all up more than 40% in 2024. The biggest market moves could still be ahead of us, and there are seven nuclear energy stocks that could rise much higher in the next several months. To unlock these tickers, enter your email address below.

Get This Free Report
Like this article? Share it with a colleague.